NFE2L2 and diabetes mellitus: These marine compounds can regulate redox-sensitive signaling pathways such as Nrf2/ARE activation and NF-κB inhibition, which make these bioactive agents’ effective modulators in controlling not only primary metabolic defects in diabetes, but also in the prevention and treatment of secondary complications.